Benutzer: Gast  Login
Titel:

Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial.

Dokumenttyp:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Article
Autor(en):
Schulz, S; Mehilli, J; Ndrepepa, G; Dotzer, F; Dommasch, M; Kufner, S; Birkmeier, KA; Tiroch, K; Byrne, RA; Schömig, A; Kastrati, A
Abstract:
Abciximab reduced the combined endpoint of death, myocardial infarction (MI) and target vessel revascularization in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) undergoing percutaneous coronary intervention (PCI) with stent implantation after a 600-mg loading dose of clopidogrel. The aim of the present study was to investigate the impact of abciximab on the evolution of left ventricular ejection fraction (LVEF) in these patients.The current study included 1,158 pati...     »
Zeitschriftentitel:
Clin Res Cardiol
Jahr:
2011
Band / Volume:
100
Heft / Issue:
8
Seitenangaben Beitrag:
691-9
Sprache:
eng
Volltext / DOI:
doi:10.1007/s00392-011-0299-y
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/21384174
Print-ISSN:
1861-0684
TUM Einrichtung:
I. Medizinische Klinik und Poliklinik (Kardiologie)
 BibTeX